Shaolin Capital Management »

Biomarin Pharma Inc convertible/ shares owned by Shaolin Capital Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Shaolin Capital Management from 13F filings

Historical chart of Shaolin Capital Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Shaolin Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Shaolin Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 4.0M 0.97

More positions owned by Shaolin Capital Management

Palo Alto Networks Note 0.375% 6/0 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dish Network Corporation Note 12/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Splunk Note 1.125% 9/1 (Principal)
Zillow Group Note 0.750% 9/0 (Principal)
Smart Global Hldgs Note 2.250% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Pebblebrook Hotel Tr Note 1.750%12/1 (Principal)
Integra Lifesciences Hldgs C Note 0.500% 8/1 (Principal)
Dropbox Note 3/0 (Principal)
Lci Inds Note 1.125% 5/1 (Principal)
Microstrategy Cl A New (MSTR)

View all positions for Shaolin Capital Management

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Partner Fund Management
Bank of America Corporation
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
MacKay Shields
Palisade Capital Management
Man Group
Royal Bank of Canada

View all funds holding Biomarin Pharma Inc convertible/